enVVeno Medical Future Growth
Future criteria checks 3/6
enVVeno Medical is forecast to grow earnings and revenue by 58.6% and 95.9% per annum respectively while EPS is expected to grow by 68.9% per annum.
Key information
58.6%
Earnings growth rate
68.9%
EPS growth rate
| Medical Equipment earnings growth | 16.1% |
| Revenue growth rate | 95.9% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 08 Mar 2024 |
Recent future growth updates
Recent updates
Companies Like enVVeno Medical (NASDAQ:NVNO) Are In A Position To Invest In Growth
Mar 07
Will enVVeno Medical (NASDAQ:NVNO) Spend Its Cash Wisely?
Aug 14Is enVVeno Medical (NASDAQ:NVNO) In A Good Position To Deliver On Growth Plans?
Apr 22We're Not Very Worried About enVVeno Medical's (NASDAQ:NVNO) Cash Burn Rate
Dec 21enVVeno Medical: Unique Exposure To Venous Treatment Domain
Sep 23We're Hopeful That enVVeno Medical (NASDAQ:NVNO) Will Use Its Cash Wisely
Aug 23enVVeno Medical reports Q2 results
Aug 03We Think enVVeno Medical (NASDAQ:NVNO) Can Afford To Drive Business Growth
May 10We're Not Very Worried About enVVeno Medical's (NASDAQ:NVNO) Cash Burn Rate
Jan 25Hancock Jaffe Laboratories: Developing Nature-Mimetic Bioprosthetics
Sep 08Hancock Jaffe Laboratories finance chief sheds interim tag
Dec 31Hancock Jaffe approves 1:25 reverse stock split
Nov 27Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 57 | 9 | N/A | 11 | 1 |
| 12/31/2025 | 24 | -15 | N/A | -6 | 1 |
| 12/31/2024 | N/A | -26 | N/A | -19 | 1 |
| 12/31/2023 | N/A | -24 | -19 | -19 | N/A |
| 9/30/2023 | N/A | -24 | -18 | -18 | N/A |
| 6/30/2023 | N/A | -25 | -18 | -18 | N/A |
| 3/31/2023 | N/A | -26 | -17 | -17 | N/A |
| 12/31/2022 | N/A | -25 | -16 | -16 | N/A |
| 9/30/2022 | N/A | -27 | -15 | -15 | N/A |
| 6/30/2022 | N/A | -24 | -13 | -13 | N/A |
| 3/31/2022 | N/A | -19 | -12 | -11 | N/A |
| 12/31/2021 | N/A | -17 | -12 | -12 | N/A |
| 9/30/2021 | N/A | -12 | -12 | -11 | N/A |
| 6/30/2021 | N/A | -12 | -12 | -12 | N/A |
| 3/31/2021 | N/A | -11 | -11 | -10 | N/A |
| 12/31/2020 | N/A | -10 | -8 | -8 | N/A |
| 9/30/2020 | N/A | -7 | -7 | -7 | N/A |
| 6/30/2020 | N/A | -7 | -6 | -5 | N/A |
| 3/31/2020 | N/A | -7 | -6 | -6 | N/A |
| 12/31/2019 | 0 | -8 | -6 | -6 | N/A |
| 9/30/2019 | 0 | -7 | -6 | -6 | N/A |
| 6/30/2019 | 0 | -7 | -6 | -6 | N/A |
| 3/31/2019 | 0 | -13 | -6 | -6 | N/A |
| 12/31/2018 | 0 | -16 | -6 | -6 | N/A |
| 9/30/2018 | 0 | -18 | -6 | -6 | N/A |
| 6/30/2018 | 0 | -19 | -6 | -6 | N/A |
| 3/31/2018 | 0 | -12 | -5 | -5 | N/A |
| 12/31/2017 | 0 | -8 | -4 | -4 | N/A |
| 9/30/2017 | 1 | -7 | N/A | -4 | N/A |
| 6/30/2017 | 1 | -5 | N/A | -3 | N/A |
| 3/31/2017 | 1 | -6 | N/A | -3 | N/A |
| 12/31/2016 | 1 | -6 | N/A | -3 | N/A |
| 9/30/2016 | 0 | -5 | N/A | -4 | N/A |
| 12/31/2015 | N/A | -1 | N/A | -2 | N/A |
| 12/31/2014 | 0 | -1 | N/A | 0 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: NVNO is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.4%).
Earnings vs Market: NVNO is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: NVNO is expected to become profitable in the next 3 years.
Revenue vs Market: NVNO is forecast to have no revenue next year.
High Growth Revenue: NVNO is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if NVNO's Return on Equity is forecast to be high in 3 years time